Medscape
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of nonproliferative diabetic retinopathy, researchers have found. Data from two phase 3 trials — Pagoda and Pavilion — demonstrate how the delivery system…
Read More
Port System Cuts Injection Burden in Diabetic Eye Disease
Lloyd Schildgen
13:22
Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of nonproliferative diabetic retinopathy, researchers have found. Data from two phase 3 trials — Pagoda and Pavilion — demonstrate how the delivery system…
